Guiding Pharmaceutical Industry Engagement in AMR: Antimicrobial Resistance Benchmark 2020; Methodology 2019 | NLM

Disaster Information Management Research Center | NLM

Guiding Pharmaceutical Industry Engagement in AMR: Antimicrobial Resistance Benchmark 2020; Methodology 2019

02/14/2019 12:00 AM EST

Source: Access to Medicine Foundation. Published: 2/14/2019. This 48-page document is the latest framework for tracking how pharmaceutical companies are responding to antimicrobial resistance (AMR), and sets out the methodology for the Antimicrobial Resistance Benchmark 2020. The AMR Benchmark 2020 measures 30 pharmaceutical companies, representing a cross-section of the pharmaceutical industry active in antibacterials and antifungals. (PDF)